x
Filter:
Filters applied
- JLR Patient-Oriented and Epidemiological Research
- epidemiologyRemove epidemiology filter
- cardiovascular diseaseRemove cardiovascular disease filter
Publication Date
Please choose a date range between 2017 and 2021.
Author
- Ala-Korpela, Mika1
- Boehnke, Michael1
- Burant, Charles F1
- Djousse, Luc1
- Fretts, Amanda M1
- Hoofnagle, Andrew N1
- Howard, Barbara V1
- Jackson, Anne U1
- Jensen, Paul N1
- Kangas, Antti J1
- Kim, Daniel Seung1
- King, Irena B1
- Kuusisto, Johanna1
- Laakso, Markku1
- Lemaitre, Rozenn N1
- Li, Yatong K1
- McKnight, Barbara1
- Salomaa, Veikko1
- Siscovick, David S1
- Sitlani, Colleen M1
- Soininen, Pasi1
- Sotoodehnia, Nona1
- Speliotes, Elizabeth K1
- Stringham, Heather M1
- Umans, Jason1
Keyword
- apolipoprotein B-1001
- C-reactive protein1
- Cardiovascular Health Study1
- Cer1
- ceramide1
- ceramides1
- CHD1
- CHS1
- cohort study1
- coronary heart disease1
- Cox proportional hazards1
- CRP1
- CVD1
- diabetes1
- elderly1
- hazard ratios1
- National Heart, Lung, and Blood Institute1
- NHLBI1
- nonalcoholic fatty liver disease1
- saturated fatty acids1
- sphingomyelins1
- transmembrane 6 superfamily member 21
- type 2 diabetes1
JLR Patient-Oriented and Epidemiological Research
2 Results
- Patient-oriented and Epidemiological ResearchOpen Access
Plasma ceramides containing saturated fatty acids are associated with risk of type 2 diabetes
Journal of Lipid ResearchVol. 62100119Published online: September 20, 2021- Amanda M. Fretts
- Paul N. Jensen
- Andrew N. Hoofnagle
- Barbara McKnight
- Barbara V. Howard
- Jason Umans
- and others
Cited in Scopus: 0Recent studies suggest that the type of saturated fatty acid bound to sphingolipids influences the biological activity of those sphingolipids. However, it is unknown whether associations of sphingolipids with diabetes may differ by the identity of bound lipid species. Here, we investigated associations of 15 ceramide (Cer) and SM species (i.e., all sphingolipids, measured with coefficient of variation less than 20%) with incident type 2 diabetes in the Cardiovascular Health Study (n = 3,645), a large cohort study of cardiovascular disease among elderly adults who were followed from 1989 to 2015. - Patient-Oriented and Epidemiological ResearchOpen Access
Novel association of TM6SF2 rs58542926 genotype with increased serum tyrosine levels and decreased apoB-100 particles in Finns
Journal of Lipid ResearchVol. 58Issue 7p1471–1481Published online: May 24, 2017- Daniel Seung Kim
- Anne U. Jackson
- Yatong K. Li
- Heather M. Stringham
- Johanna Kuusisto
- Antti J. Kangas
- and others
Cited in Scopus: 39A glutamate-to-lysine variant (rs58542926-T) in transmembrane 6 superfamily member 2 (TM6SF2) is associated with increased fatty liver disease and diabetes in conjunction with decreased cardiovascular disease risk. To identify mediators of the effects of TM6SF2, we tested for associations between rs58542926-T and serum lipoprotein/metabolite measures in cross-sectional data from nondiabetic statin-naïve participants. We identified independent associations between rs58542926-T and apoB-100 particles (β = −0.057 g/l, P = 1.99 × 10−14) and tyrosine levels (β = 0.0020 mmol/l, P = 1.10 × 10−8), controlling for potential confounders, in 6,929 Finnish men.